Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients
نویسندگان
چکیده
Randall J. Nett, Jared L. Bartschi, Giovanina M. Ellis, David M. Hachey, Lisa M. Frenkel, J. Clay Roscoe, Kris K. Carter, and Christine G. Hahn Author affi liations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (R.J. Nett, K.K. Carter); Idaho Department of Health and Welfare, Boise, Idaho, USA (R.J. Nett, J.L. Bartschi, J.C. Roscoe, K.K. Carter, C.G. Hahn); Seattle Children’s Hospital Research Institute, Seattle, Washington, USA (G.M. Ellis, L.M. Frenkel); Idaho State University, Pocatello, Idaho, USA (D.M. Hachey); University of Washington, Seattle (L.M. Frenkel); and Family Medicine Residency of Idaho, Boise (J.C. Roscoe)
منابع مشابه
H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients
Most oseltamivir-resistant pandemic (H1N1) 2009 viruses have been isolated from immunocompromised patients. To describe the clinical features, treatment, outcomes, and virologic data associated with infection from pandemic (H1N1) 2009 virus with H275Y mutation in immunocompromised patients, we retrospectively identified 49 hematology-oncology patients infected with pandemic (H1N1) 2009 virus. S...
متن کاملOseltamivir Resistance in Adult Oncology and Hematology Patients Infected with Pandemic (H1N1) 2009 Virus, Australia
We describe laboratory-confirmed influenza A pandemic (H1N1) 2009 in 17 hospitalized recipients of a hematopoietic stem cell transplant (HSCT) (8 allogeneic) and in 15 patients with malignancy treated at 6 Australian tertiary centers during winter 2009. Ten (31.3%) patients were admitted to intensive care, and 9 of them were HSCT recipients. All recipients of allogeneic HSCT with infection <100...
متن کاملInfluenza A/H1N1 in pediatric oncology patients.
BACKGROUND Our aim was to determine the clinical and epidemiological features of pandemic influenza A/H1N1 in immunocompromised children with solid tumors and hematological malignancies. PATIENTS AND METHODS A prospective study was conducted during the H1N1 pandemic between August 2009 and February 2010 in a pediatric hematology-oncology unit. Demographic and clinical data were obtained from ...
متن کاملCharacterization of Oseltamivir-Resistant 2009 H1N1 Pandemic Influenza A Viruses
Influenza viruses resistant to antiviral drugs emerge frequently. Not surprisingly, the widespread treatment in many countries of patients infected with 2009 pandemic influenza A (H1N1) viruses with the neuraminidase (NA) inhibitors oseltamivir and zanamivir has led to the emergence of pandemic strains resistant to these drugs. Sporadic cases of pandemic influenza have been associated with muta...
متن کاملPandemic (H1N1) 2009 Reinfection, Chile
(H1N1) became resistant to both oseltamivir and amantadine in a short span of 1 month. Oseltamivir-resistant A/Brisbane/59/2007-like clade 2B virus that had reassorted with A/Hong Kong/2652/2006-like clade 2C virus had apparently spread in the community and to other regions of the world. The possibility of reassortment with pandemic (H1N1) 2009 virus is a major concern. Resistance to oseltamivi...
متن کاملOseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infection in England and Scotland, 2009–2010
Oseltamivir has been widely used for pandemic (H1N1) 2009 virus infection, and by April 30, 2010, a total of 285 resistant cases were reported worldwide, including 45 in the United Kingdom. To determine risk factors for emergence of oseltamivir resistance and severe infection, a case-control study was conducted in the United Kingdom. Study participants were hospitalized in England or Scotland d...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 16 شماره
صفحات -
تاریخ انتشار 2010